Results for “ ”

Entry Author Date Location
Amid Acquisition Drama, Celgene Resubmits MS Drug for FDA Approval 03/25/19 New York
Thermo Bags Brammer For $1.7B as Gene Therapy Deal Spree Continues 03/25/19 Boston
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More 03/22/19 National
Adieu to Adu: Biogen’s Big Alzheimer’s Bet Flops, Shares Routed 03/21/19 Boston
As Exact Sciences’ Sales Surge, CEO Reflects on 10-Year Turnaround 03/20/19 Wisconsin
Pfizer Bolsters Gene Therapy Position with $51M Vivet Deal 03/20/19 New York
New Accelerator Aims For Social Change With AR, VR, Gaming Startups 03/20/19 San Francisco
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take 03/19/19 Boston
Erie Hack Aims to Solve Lake’s Challenges with Tech-Driven Solutions 03/19/19 Detroit Ann Arbor
Urovant Bladder Drug Hits Test Goals But Can’t Outpace Generic Rival 03/19/19 San Diego
Coming Home Again: Estrada Returns to Lead WeWork Labs in Houston 03/19/19 Texas
Dermira Shares Soar After Eczema Drug Hits Goal of Mid-Stage Study 03/18/19 San Francisco
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
FDA Clears Aerie’s Combo Glaucoma Drug, But Will it Sell? 03/13/19 New York
The Investments Cisco, Samsung, Toyota, and Chevron Are Making in AI 03/13/19 Texas
Drug-Price Watchdog ICER Dives into Trump-Fueled Pharma Rebate Debate 03/13/19 National
Celgene Submits MS Drug for Approval in Europe, FDA Filing on Track 03/11/19 New York
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More 03/08/19 National
Steering Lyft’s IPO: What Investors Will Weigh During the Roadshow 03/07/19 San Francisco
Intel Reveals Ideas on Promoting AI in U.S. as Chinese Growth Looms 03/06/19 San Francisco
Blue Squad Aims to Bring Election Tech Up and Down the Ballot 03/06/19 National
A Glimpse of A.I.’s Future? MIT-IBM Research Lab Sees Early Progress 03/06/19 Boston
Two Years and Done: FDA Commissioner Gottlieb To Resign 03/05/19 National
Retailers Turn to Analytics, 3D Tech to Promote Fit, Reduce Returns 03/04/19 National
After AGTC Deal Flops, Biogen Bets $800M on Gene Therapy Rival Nightstar 03/04/19 Boston
Privacy Watch: FTC, Facebook, EU, the Cloud Act, & More CA bills 03/04/19 San Francisco
SPECIAL REPORT: 2019 Biopharma Outlook – Facing an Uncertain Future 03/01/19 National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark 03/01/19 National
Ex-Google CEO: New MIT College Could Help Shrink A.I. Talent Gap 02/28/19 Boston
Page 2 of 142 « previous page · next page »